Long-term Safety of Dasatinib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Clinical trial NCT00982488 · COMPLETED
Trial details
- NCT number
- NCT00982488
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2014-12-01
- Enrollment
- 238
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.